Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock $0.001 par value per share
-
Shares outstanding
-
77.8M
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
82.2M
-
Shares change
-
+3.37M
-
Total reported value, excl. options
-
$400M
-
Value change
-
+$32.1M
-
Put/Call ratio
-
0.23
-
Number of buys
-
75
-
Number of sells
-
-47
-
Price
-
$4.87
Significant Holders of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) as of Q2 2025
149 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share as of Q2 2025.
Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.2M shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11.9M shares), Bain Capital Life Sciences Investors, LLC (7.91M shares), Siren, L.L.C. (7.42M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (6.73M shares), RA CAPITAL MANAGEMENT, L.P. (5.81M shares), BlackRock, Inc. (4.92M shares), VANGUARD GROUP INC (3.37M shares), FMR LLC (3.18M shares), CITADEL ADVISORS LLC (2.52M shares), and Monashee Investment Management LLC (2.17M shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.